Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

7.2K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same author

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.

Antiviral research·2026
Same author

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

Clinical and translational science·2026
Same author

Comment on: Retrospective analysis of pharmacological therapeutic monitoring of caspofungin in patients undergoing continuous renal replacement therapy using polyacrylonitrile membranes.

The Journal of antimicrobial chemotherapy·2026
Same author

Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant.

Journal de mycologie medicale·2026
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K

[Not Available].

Caroline Solas1, Marie-Claude Gagnieu2,

  • 1Laboratoire de Pharmacocinétique et Toxicologie, Hôpital de La Timone, Marseille, France.

Therapie
|July 10, 2016
PubMed
Summary
This summary is machine-generated.

Therapeutic drug monitoring for efavirenz, an HIV-1 treatment, is recommended. Monitoring plasma concentrations helps optimize viral response and prevent central nervous system toxicity.

Keywords:
efavirenzlevel of evidenceniveau de preuvesuivi thérapeutique pharmacologiquetherapeutic drug monitoring

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K
Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Area of Science:

  • Pharmacology
  • Virology
  • Genetics

Context:

  • Efavirenz, a non-nucleoside reverse transcriptase inhibitor for HIV-1, exhibits significant pharmacokinetic variability due to hepatic metabolism and induction.
  • Central nervous system (CNS) toxicity is a primary driver of non-adherence and treatment failure in efavirenz therapy.

Purpose:

  • To evaluate the evidence supporting therapeutic drug monitoring (TDM) for efavirenz.
  • To determine if TDM can optimize viral response and mitigate CNS toxicity.

Summary:

  • Higher efavirenz plasma concentrations (>1000 ng/mL) predict viral response, while concentrations >4000 ng/mL increase CNS side effects.
  • The CYP2B6*6 allele (516G>T mutation) is linked to increased efavirenz exposure and higher CNS toxicity risk.
  • Non-randomized studies suggest TDM is beneficial for optimizing efavirenz therapy.

Impact:

  • Recommends therapeutic drug monitoring for efavirenz based on current evidence.
  • Highlights the role of TDM in personalized HIV-1 treatment strategies.
  • Aims to improve patient adherence and treatment outcomes by managing efavirenz toxicity.